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Abstract
Background: Several humoral immune factors are responsible for a successful pregnancy. There
are a few studies, which demonstrate the role of antipaternal cytotoxic antibodies (APCA) and
mixed lymphocyte reaction blocking factor (MLR-Bf) in the maintenance of pregnancy. However,
these factors have not been studied in women with history of recurrent spontaneous abortion
(RSA). We designed this study to review the role of APCA and MLR-Bf in normal pregnancy as well
as in women with a history of RSA.
Methods: One hundred and five women with unexplained recurrent spontaneous abortion were
included in the present study. These women were screened for all other known causes of
recurrent abortion. We also included 60 normal fertile women, fifteen from each trimester and
fifteen women during the post partum period (up to six months). RSA and controls (normal
pregnancy) were matched for age, caste, and socio economic background and also for parity. APCA
and MLR-Bf were evaluated in all the groups. All women with RSA who conceived during the study
period were on follow up.
Results: We have analyzed the status of APCA and MLR-Bf in normal pregnancy (different
gestational periods and during post partum), and in women with history of RSA. Our results show
that APCA was significantly higher in controls as compared to RSA women. MLR-Bf was directed
against the husbands' cells in normal pregnancy and was virtually absent in RSA women.
Conclusion: Our results indicate that there is a significantly low titer of APCA and MLR-Bf in
women with recurrent spontaneous abortion. This highlights the role of these factors in the
maintenance of successful pregnancy.
Background
The foetus is a semi allograft as it contains 50% of the
MHC genes from the father. It is potentially recognized as
an alien and consequently rejected by the mother. Never-
theless, it is carried to term in normal pregnancy. Several
investigators have proposed that tolerance to foetal al-
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nancy and its failure leads to recurrent spontaneous
abortion (RSA). Active induction of tolerance is probably
mediated by anti-paternal cytotoxic antibodies (APCA)
[1] and immunologically specific mixed lymphocyte reac-
tion blocking factor (MLR-Bf) [2]. However, various stud-
ies on humoral markers in women with RSA have yielded
contradictory results. No single immunological marker
has been found to be of diagnostic or prognostic value in
RSA.
In the present study both these parameters viz., APCA and
MLR-Bf have been investigated in normal fertile women
during different trimesters of pregnancy and post-delivery
and in RSA women. It was seen that the level of APCA and
MLR-Bf were significantly low in women with RSA as
compared to those with normal pregnancy. Quantitative
evaluation of these parameters may serve as a marker for
identification of women with RSA who may be benefited
by immunization against their husband's lymphocytes.
Methods
Two hundred and five RSA women with history of 3 or
more consecutive abortions attending the genetics OPD
(Out Door Patients) from March 1996 to July 2001 were
included in the study. 149 were primary aborters with
more then 3 subsequent foetal losses and 56 were second-
ary aborters. As per the study design, all these women
were investigated to exclude the known cause of RSA (se-
rological tests for toxoplasma, glucose tolerance test, hys-
terosalpingogram, thyroid function test, luteal phase
plasma progesterone assay, anticardiolipin antibody, an-
tiphospholipid antibody, antinuclear antibody test and
chromosomal abnormalities of both husband and wife).
One hundred and five women who were negative for all
the above tests and also not lost to follow up during these
investigations were investigated for APCA and MLR-Bf. In
RSA women the APCA and MLR-Bf tests were performed
within one month of the abortion. Some of these women
conceived during follow up. The APCA and MLR-Bf was
again tested as soon as the pregnancy was confirmed.
The control group included 60 normal fertile women, 15
each in all the three trimesters of pregnancy and 15 in the
post-partum period upto 6 months after delivery. Women
of control group i.e. only those women who had 3 or
more living children were considered.
APCA assay
Anti-paternal cytotoxic antibodies were detected using
National Institute of Health (NIH) protocol. Serial dilu-
tion of maternal serum from 1:2 to 1: 64 was cross-
matched with the paternal blood lymphocytes at three dif-
ferent temperature (i.e. 4°C, 22°C and 37°C). This was
done as some of the antibodies are activated at 4°C (cold
antibodies), some at 37°C (warm antibodies) while oth-
ers are activated at room temperature. Cross match was
done against both T and B cells. A positive result was re-
corded when more than 80–100% cell death was ob-
served.
Mixed lymphocyte reaction (MLR)
The mixed lymphocyte reaction-blocking factor (MLR-Bf)
was investigated in one-way MLR with cells from the
spouse and also against any other unrelated male. Blood
was collected under sterile conditions, and peripheral
blood mononuclear cells (PBMC) were isolated from
heparinized whole blood by density gradient centrifuga-
tion on ficoll-hypaque gradient. Cells were adjusted to 5 ×
105/ml and were divided into two halves. One half was ir-
radiated (1250 rad), and the irradiated cells were used as
stimulators. The non-irradiated cells were used as re-
sponders. Cultures were set up in triplicate. For measure-
ment of DNA synthesis, cultures were pulsed with 1 µCi/
well of [3H] thymidine 18 hrs before harvesting, and the
incorporated radioactivity was measured by liquid scintil-
lation counting.
MLR blocking activity was estimated using stimulation in-
dex (SI), which was calculated according to the following
formula
where cpm = count per minute, P = Paternal, M = Maternal
and MLR = mixed lymphocyte reaction.
Prevalence of APCA and MLR-Bf in the study and control
groups was analyzed by using Chi-square test and analysis
of variance (ANOVA).
Results
Prevalence of anti-paternal cytotoxic antibody in 60 nor-
mal fertile couples in different gestational periods and
105 women with RSA is as depicted in Table 1. APCA (titer
of ≥ 1:16) were present in 46.66% and 33.33% of the sam-
ples in the first and second trimesters subsequently. The
titer value in third trimester ranged between 1:4 to 1:64,
however, there was a sudden rise of APCA titer during
postpartum period of pregnancy i.e. 1:64 to 1:256. In RSA
women immediately after abortion APCA was present
only in 8.57% samples (titer value ranged between 1:2 to
1:4). We also analyzed the APCA titer in 60 RSA women
who became pregnant during follow up and found that
the APCA positivity was seen in only 6.66% women and
the titer value ranged 1:2 to 1:4. The difference of APCA
titer between normal pregnancy and women with RSA was
highly significant (p < 0.001). The lowest dilution at
StimulationIndex(SI)
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Hence, the cut off limit was taken as 1:2. It is interesting
to note that the maximum titer (1:256) was seen one-
month post delivery after which it declined to 1:2.
From table 2 it is evident that stimulation index (SI) val-
ues in wife serum (WS) were less than in pooled human
serum (PHS) in all the trimesters of pregnancy in normal
fertile women which is statistically significant (P < 0.001),
though this difference was less marked in the post-partum
period (P < 0.05). However, in two groups of RSA women
(i.e. RSA women with one month of post abortion and
RSA women with 1 – 3 month of pregnancy) the SI was al-
most similar in PHS or WS.
In normal pregnancy, three gestational periods i.e. 1st,
2nd, 3rd, trimester and 1 – 6 months post partum were
compared with one another. Our results (Table 2) demon-
strated that there was depressed SI in the 1st trimester
while it increased gradually in 2nd, 3rd and post delivery
period. To find out whether blocking activity was specific
to the husband's cells or not we used ANOVA followed by
logistic regression analysis on the data obtained from all
the possible combinations in the mixed lymphocyte reac-
tion experiments (1:2, 1:3, 1:4, 2:1, 2:3, 2:4, 3:1, 3:2, 3:4,
4:1, 4:2, 4:3) on normal pregnant and RSA women.
Number 1 is for RSA women, 2 for husband of RSA wom-
en, 3 for normal pregnant women and 4 for husband of
normal pregnant women. It is evident from the odds ra-
tios (Figure 1) that the blocking activity present in the nor-
mal pregnancy is directed only against the husband's cells
and not against the cells of the controls. To show the sig-
nificance of this observation F statistics was applied which
revealed that husband's and wife's cells were least prolif-
erated in the wife serum as compared to all other combi-
nations of normal pregnancy group (F= 8.2853, p <
0.001). In RSA women there was no difference in the pro-
liferation in any of the possible combinations (F = 3.54, p
> 0.05) indicating that MLR-Bf is absent in this group.
Table 1: Anti paternal cytotoxic antibody (APCA) in couples with Normal fertility compared towomen with RSA.
Group of Patients No. of couples No. of APCA +ve 
*
Range of APCA titer % +ve
Normal pregnant women
* 0–3 month 15 7 1:2 – 1:16 46.66
* 4–6 month 15 5 1:4 – 1:32 33.33
*7–9 month 15 6 1:8 – 1:64 40.00
Post delivery
* 0–6 month 15 6 1:2 – 1:256 40.00
Women with RSA
* One month post abortion 105 9 1:2 – 1:4 8.57
** 1 – 3 month pregnancy (RSA women) 60 4 1:2 – 1:4 6.66
* Any titer ≥ 1:2 was taken as positive RSA vs. Control : X2 = 28.781 p < 0.001 ** RSA women after pregnancy on regular follow up Non pregnant 
RSA vs. Pregnant RSA X2 = 0.192 p > 0.05
Table 2: Mean stimulation index in normal pregnancy compared to women with RSA
Group of patients SI in PHS (Mean ± SD) SI in WS (Mean ± SD)
Ist Trimester 11.17 ± 4.75 2.91 ± 1.2
IInd Trimester 9.36 ± 4.67 4.18 ± 2.44
IIIrd Trimester 11.05 ± 3.02 6.58 ± 2.59
Post Delivery (upto 6 months) 15.92 ± 4.60 12.71 ± 5.57
RSA (1 month post abortion) 7.37± 3.64 9.41± 3.77
RSA (1–3 month of pregnancy) 9.88 ± 3.37 10.30 ± 2.25
PHS – pooled human AB male serum WS – wife's serumPage 3 of 6
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This study deals with the alloimmune mechanisms in-
volved in the maintenance of pregnancy. Several humoral
immune factors have been implicated to play a role in ma-
ternal immuno-modulation but their significance is con-
troversial. Great deal of doubt and confusion exists
regarding the choice of a marker for evaluating efficacy of
immunotherapy for treatment of RSA. Anti-paternal cyto-
toxic antibodies (APCA) and mixed lymphocyte reaction-
blocking factor (MLR-Bf) are the commonly used param-
eters [3,4]. Anti-idiotypic antibody (AB2) [5] and human
embryonic antigen [6] have also been used as potential
markers.
In this study, anti-paternal cytotoxic antibodies (APCA)
were present in only 8.5% women with RSA. In women
with RSA who became pregnant during the study period,
APCA was present in 6.66% as compared to 33 – 46% in
the control group (p < 0.001). Regan et al. [1] have report-
ed 10% APCA positivity in RSA patients compared to 32%
during normal pregnancy. Similarly, Hasegawa et al. [7]
have reported less than 8.7% APCA positivity in women
Figure 1
Univariate logistic regression analysis for presence of MLR-Bf in different combinations. (1-RSA women, 2-husband of RSA
women, 3-normal pregnant women, 4-husband of normal pregnant women)
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cated that APCA titer of ≥ 1:16 is a significant predictor of
a successful pregnancy outcome following immunization
with husband's lymphocytes [3]. Dudley and Branch [8]
have also concluded that development of APCA may be
an appropriate marker of maternal recognition of foeto-
paternal antigens; however, its absence is of questionable
significance as only 20–25% of multiparous women were
found to be positive for APCA. On the other hand, Cow-
chock et al. [9] have totally excluded the role of APCA and
MLR-Bf in the prediction of pregnancy outcome. In RSA
women APCA titer was either absent or quite low when
tested immediately after abortion or a month after abor-
tion. However, in normal pregnancy it was present in ad-
equate titers.
Serum factors suppressing mixed lymphocyte reaction
were assessed on the basis of stimulation index. In most
of the RSA women the SI value in maternal serum was
higher as compared to pooled human serum, indicating
that the sera of women with RSA do not contain MLR-Bf.
Tamura et al [2] found MLR-blocking antibodies in 82.4%
women with normal pregnancy against only 10% in
women with RSA. Similar foetoprotective effect of block-
ing factor has been reported by various other investigators
[2,4,10–14]. Our study on time-kinetics of MLR-Bf during
the course of a successful pregnancy showed maximum
levels during the first trimester and a progressive decline
through the subsequent trimesters and post-delivery peri-
od. However, Tamura et al. [2] have shown that the block-
ing effect increases with progression of pregnancy. They
have also shown that once the blocking factor is formed it
is helpful in the subsequent pregnancies.
There are other studies, which do not support this hypoth-
esis [15–18]. We have further carried out the regression
analysis to find out whether the blocking antibody was di-
rected towards the husband's cells or not. It was found
that the blocking factor was specific to husband's cells on-
ly. When logistic regression analysis was carried on the SI
values for different combinations of each set of mixed
lymphocyte reaction experiment (Figure 1) these results
were further confirmed. It can be observed that the odds
of greatest blocking activity happen to be in the first tri-
mester against husband's cells only.
Conclusion
The present study clearly demonstrates that alloimmune
mechanisms may play a protective role by blocking the ef-
fect of maternal lymphocytes against an alien trophoblast.
The MLR-Bf may camouflage the HLA antigen on the foe-
tus, there by blocking the afferent limb of the maternal
immunological response. The relative absence of these
factors (APCA and MLR-Bf) in patients with RSA in our
study emphasizes their role in the maintenance of normal
pregnancy. This was further confirmed by ANOVA and lo-
gistic regression analysis, which indicated that MLR-Bf
was directed only against husband's cells. Thus, these
markers should not be disregarded or abandoned alto-
gether while considering the role of other humoral fac-
tors.
Competing interests
This study was supported by a research grant-in-aid from
the Indian Council of Medical Research (ICMR), Govt. of
India.
Authors' Contributions
SA drafted and planned the study. MKP carried out all of
the experiments. LCM performed the sequence alignment
experiments. SKM carried out the statistical analysis of the
results. SSA conceived the study and participated in its de-
sign and coordination.
References
1. Regan L, Braude PR, Hill DP: A prospective study of the inci-
dence, time of appearance & significance of anti-paternal
lymphocytotoxic antibodies in human pregnancy. Hum Reprod
1991, 6:294-298
2. Tamura M, Takakuwa K, Arakawa M, Yasuda M, Kazama Y, Tanaka K:
Relationship between MLR blocking antibodies and the out-
come of the third pregnancy in patients with two conseq-
utive spontaneous abortions. J Perinat Med 1998, 26:49-53
3. Agrawal S, Kishore R, Halder A, Sharma A, Sharma RK, Das V, Shukla
BRK, Agarwal SS: Outcome of pregnancy in women with recur-
rent spontaneous abortion following immunotherapy with
Allogenic lymphocytes. Hum Reprod 1995, 10:2280-2284
4. Agrawal S, Pandey MK, Pandey A: Prevalence of MLR blocking
antibodies before and after immunotherapy. J Hematother Stem
Cell Res 2000, 9:257-262
5. Behar E, Carp H, Livneh A, Gazit E: Anti-idiotypic IgM antibodies
to anti-HLA class I antibodies in habitual abortion. Am J Reprod
Immunol 1991, 26:143-146
6. Shiraishi S, Shiraishi Y, Yamamoto O, et al: Diagnostic relevance of
abortionassociated human embryonic antigen expressed on
the cell surface of tumor promoter treated bloom syndrome
cells. Hum Reprod 1995, 10:1694-1701
7. Hasegawa I, Tani H, Takakuwa K, Goto S, Yamada K, Kanazawa K: A
new lymphocyte serotyping using cytotoxic antibodies from
secondary recurrent aborters and its application in cases of
recurrent abortion and infertility. Fertil Steril 1991, 55:906-910
8. Dudley DJ, Branch DW: New approaches to recurrent pregnan-
cy loss. Clin obstet Gynecol 1989, 32:520-532
9. Cowchock FS, Smith JB: Predict for live birth after unexplained
spontaneous abortions: correlation between immunologic
test results, obstetric histories and outcome of next preg-
nancy without treatment. Am J Obstst Gynecol 1992, 167:1208-
1212
10. Power DA, 0Mather AJ, Macleod AM, Lind T, Catto GR: Maternal
antibodies to paternal B-lymphocytes in normal & abnormal
pregnancy. Am J Reprod Immunol Microbiol 1986, 10:10-13
11. Ramhorst R, Agriello E, Zittermann S, Pando M, Larriba J, Irigoyen M,
Cortelezzi M, Auge L, Lombardi E, Etchepareborda JJ, Contreras Or-
tiz C, Fainboim L: Is the paternal mononuclear cells' immuni-
zation a successful treatment for recurrent spontaneous
abortion? Am J Reprod Immunol 2000, 44:129-135
12. Zenclussen AC, Gentile T, Kortebani G, Mazzolli A, Margni R: Asym-
metric antibodies and pregnancy. Am J Reprod Immunol 2001,
45:289-294
13. Malinowski A, Zemen K, Wilczynski J, Glowacka E, Banasik M, Powi-
erza S, Pokoca L, Szpakowski M: Immunologic characteristics of
women with recurrent spontaneous abortion of unknown
etiology – II. Characterisation of humoral immunology. Gine-
kologia Polska 1997, 68:240-247Page 5 of 6
(page number not for citation purposes)
BMC Pregnancy and Childbirth 2002, 2 http://www.biomedcentral.com/1471-2393/2/6Publish with BioMed Central  and  every 
scientist can read your work free of charge
"BioMedcentral will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Paul Nurse, Director-General, Imperial Cancer Research Fund
Publish with BMC and your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours - you keep the copyright
editorial@biomedcentral.com
Submit your manuscript here:
http://www.biomedcentral.com/manuscript/
BioMedcentral.com
14. Malinowski A, Wilezynski J, Zemen K, Glowacka E, Kolasa D, Szpa-
kowski A, Oszukowski P, Szpakowski M: Immunological charac-
teristics of non-pregnant women with unexplained recurrent
spontaneous abortion who underwent paternal lymphocyte
immunization. Zentralblatt fur Gynakologie 1998, 120:493-502
15. Pena RB, Cadavid AP, Botero JH, Garcia GP, Gallego MI, Ossa JE: The
production of MLR-blocking factors after lymphocyte immu-
notherapy for RSA doesnot predict the outcome of pregnan-
cy. Am J Reprod Immunol 1998, 39:120-124
16. Daher S, Fonesca F, Matter R, Musatti CC, de Lima MC: Inhibitory
serum factor of lymphoproliferative response to Allogenic
cells in pregnancy. Revista Paulista de Medicine 1997, 115:1485-
1489
17. Fonesca DSF, Matter R, Musatte CC, De Lima MC: Inhibitory se-
rum factor of lymphoproliferative response to allogenic cells
in pregnancy. Rev Paul Med 1997, 115:1485-1489
18. Jablonowska B, Palfi M, Ernerudh J, Kjellberg S, Selbing A: Blocking
antibodies in blood from patients with recurrent spontane-
ous abortion in relation to pregnancy outcome and intrave-
nous immunoglobulin treatment. Am J Reprod Immunol 2001,
45:226-231
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2393/2/6/prepubPage 6 of 6
(page number not for citation purposes)
